C.D.C. Panel Meet for Debate on Whether to Advise Pfizer Boosters for Children 5 to 11

Although the F.D.A. authorized the shots this week, hesitancy is high. Fewer than one-third of children in this age group have received two doses.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Children and Childhood Pfizer Inc BioNTech SE Centers for Disease Control and Prevention United States Source Type: news